RASYONEL İLAÇ TASARIMINDA MOLEKÜLER MEKANİK VE MOLEKÜLER DİNAMİK YÖNTEMLERİN KULLANILMA AMACI

Amaç: Bu derlemenin amacı Rasyonel İlaç Tasarımında kullanılan Moleküler Mekanik ve Moleküler Dinamik yöntemlerinin incelenmesi, yöntemlerin temelinin araştırılması, avantaj ve dezavantajlarının ortaya konmasını sağlamaktır.

THE AIM OF IMPLEMENTATION OF THE MOLECULAR MECHANIC AND THE MOLECULAR DYNAMIC METHODS IN RATIONAL DRUG DESIGN

Objective: In this rewiev, ıt’s aimed to view the Molcular Dynamics and Molecular Mechanics methods to use in Rational Drug Design, research the basics, exhibit the advantages and disadvantages of these methods.

___

  • 1- Ramachandran, K.I., Deepa, G., Namboori, K.(2008). Computational Chemistry and Molecular Modeling, Springer, Coimbatore ,p1-3,p7, p205-207.
  • 2- Schlick, T.(2010). Molecular Modeling and Simulation, Springer, New York,p3, p426-432.
  • 3- Leach, A.R.(200).Molecular Modelling Principles and Applications, Pearson Educated Limited, Harlow,p9, p165-173, p353-355.
  • 4- Hinchliffe, A.(2003).Molecular Modelling for Beginners, Wiley, Manchester, p2-4, p51-72, p123-130.
  • 5- Cohen, N.C.(1996).Guidebook on Molecular Modeling in Drug Design, Elsevier, Basel, p1-6.
  • 6- Mandal, S., Mandal, S. K. (2009). Rational drug design. European journal of pharmacology, 625(1-3), 90-100.
  • 7- Hagedorn, G. A. (1980). A time dependent Born-Oppenheimer approximation. Communications in Mathematical Physics, 77(1), 1-19. 8- Jorgensen, W. L. (2004). The many roles of computation in drug discovery. Science, 303(5665), 1813-1818.
  • 9- Van Drie, J. H. (2007). Computer-aided drug design: the next 20 years. Journal of computer-aided molecular design, 21(10-11), 591-601.
  • 10- Śledź, P., Caflisch, A. (2018). Protein structure-based drug design: from docking to molecular dynamics. Current opinion in structural biology, 48, 93-102.
  • 11- Bernardi, R. C., Melo, M. C., Schulten, K. (2015). Enhanced sampling techniques in molecular dynamics simulations of biological systems. Biochimica et Biophysica Acta (BBA)-General Subjects, 1850(5), 872-877.
  • 12- Jyothirmayee C.A.(2014).Computer-aided drug design. Life Sciences International Research Journal, 1(1)
  • 13- Shaw, D. E., Deneroff, M. M., Dror, R. O., Kuskin, J. S., Larson, R. H., Salmon, J. K., Eastwood, M. P. (2008). Anton, a special-purpose machine for molecular dynamics simulation. Communications of the ACM, 51(7), 91-97.
  • 14- Durrant, J. D., McCammon, J. A. (2011). Molecular dynamics simulations and drug discovery. BMC biology, 9(1), 71.
  • 15- De Vivo, M., Masetti, M., Bottegoni, G., Cavalli, A. (2016). Role of molecular dynamics and related methods in drug discovery. Journal of medicinal chemistry, 59(9), 4035-4061.
  • 16- Borhani, D. W., Shaw, D. E. (2012). The future of molecular dynamics simulations in drug discovery. Journal of computer-aided molecular design, 26(1), 15-26.
  • 17- Masetti, M., Rocchia, W. (2014). Molecular mechanics and dynamics: numerical tools to sample the configuration space. Frontiers in Bioscience, 19(1), 578-604.
  • 18- Hollingsworth, S. A., Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129-1143.
  • 19- Frenkel, D., Smit, B. (2002).Understanding Molecular Simulations, Academic Press,p.63-74.
  • 20- Alder, B. J., Wainwright, T. E. (1957). Phase transition for a hard sphere system. The Journal of chemical physics, 27(5), 1208-1209.
  • 21- Cheatham III, T. E.,Young, M. A. (2000). Molecular dynamics simulation of nucleic acids: successes, limitations, and promise. Biopolymers: Original Research on Biomolecules, 56(4), 232-256.
  • 22- Binder, K., Horbach, J., Kob, W., Paul, W., Varnik, F. (2004). Molecular dynamics simulations. Journal of Physics: Condensed Matter, 16(5), S429.
  • 23- Hassan Baig, M., Ahmad, K., Roy, S., Mohammad Ashraf, J., Adil, M., Haris Siddiqui, M., Choi, I. (2016). Computer aided drug design: success and limitations. Current pharmaceutical design, 22(5), 572-581.
  • 24- Ferreira, L., dos Santos, R., Oliva, G., Andricopulo, A. (2015). Molecular docking and structure-based drug design strategies. Molecules, 20(7), 13384-13421.
  • 25- Ganesan, A., Coote, M. L., & Barakat, K. (2017). Molecular dynamics-driven drug discovery: leaping forward with confidence. Drug discovery today, 22(2), 249-269.
  • 26- Schatz, G. C. (1988). Quantum effects in gas phase bimolecular chemical reactions. Annual Review of Physical Chemistry, 39(1), 317-340.
  • 27- Masetti, M., Rocchia, W. (2014). Molecular mechanics and dynamics: numerical tools to sample the configuration space. Frontiers in Bioscience, 19(1), 578-604.
  • 28- van der Vaart, A., Bursulaya, B. D., Brooks, C. L., Merz, K. M. (2000). Are many-body effects important in protein folding?. The Journal of Physical Chemistry B, 104(40), 9554-9563.
  • 29- Weiner, S. J., Kollman, P. A., Case, D. A., Singh, U. C., Ghio, C., Alagona, G., Weiner, P. (1984). A new force field for molecular mechanical simulation of nucleic acids and proteins. Journal of the American Chemical Society, 106(3), 765-784.
  • 30- Nerenberg, P. S., Head-Gordon, T. (2018). New developments in force fields for biomolecular simulations. Current opinion in structural biology, 49, 129-138.
  • 31- Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., Case, D. A. (2004). Development and testing of a general amber force field. Journal of computational chemistry, 25(9), 1157-1174.
  • 32- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y.& Kaus, J. W. (2015). OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. Journal of chemical theory and computation, 12(1), 281-296.
  • 33- Şener, E. A., Yalçın, İ. (2003). Farmasötik/Medisinal Kimya'da ilaç etken madde tasarım yöntemleri-1: kantitatif yapı-etki iİlişkileri analizleri (QSAR).p 2-6, p13-17
  • 34- Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological reviews, 66(1), 334-395.
  • 35- Bone, R. G., Bader, R. F. (1996). Identifying and analyzing intermolecular bonding interactions in van der Waals molecules. The Journal of Physical Chemistry, 100(26), 10892-10911.
  • 36- Hobza, P., Zahradník, R., Müller-Dethlefs, K. (2006). The world of non-covalent interactions: 2006. Collection of Czechoslovak Chemical Communications, 71(4), 443-531.
  • 37- Buckingham, A. D., Fowler, P. W., Hutson, J. M. (1988). Theoretical studies of van der Waals molecules and intermolecular forces. Chemical Reviews, 88(6), 963-988.
  • 38- Buckingham, A. D., Utting, B. D. (1970). Intermolecular forces. Annual Review of Physical Chemistry, 21(1), 287-316.
Ankara Üniversitesi Eczacılık Fakültesi Dergisi-Cover
  • ISSN: 1015-3918
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2016
  • Yayıncı: Ankara Üniversitesi Eczacılık Fakültesi
Sayıdaki Diğer Makaleler

TOPOİZOMERAZ II ENZİM İNHİBİTÖRLERİ

Oğuzhan FIRAT, İlkay YILDIZ

KADIN ECZACILAR PERSPEKTİFİNDEN ECZACILIK MESLEĞİ

Miray ARSLAN, Efsun Sima ÇOBAN, Sevgi ŞAR

5-(5-METİL-1H-PİRAZOL-3-İL)-4-FENİL-4H-1,2,4-TRİAZOL-3-TİYOL ALKİL TÜREVLERİNİN SENTEZ VE ANTİRADİKAL AKTİVİTELERİ

Andrey GOTSULYA

POTASYUM 2-((4-AMİNO-5-(MORFOLİNOMETİL)-4H-1,2,4-TRİAZOL-3-İL)TİYO) ASETATIN FARMAKOKİNETİĞİ VE POTANSİYEL METABOLİTLERİNİN SIÇANLARDA ARAŞTIRILMASI

Roman SHCHERBYNA

ÖNEMLİ ORTAK ÖZELLİKLERİ TANIMLAMAK AMACIYLA, BİLİNEN MMP-9 ENZİM İNHİBİTÖRLERİ ÜZERİNDE YAPILAN FARMAKOFOR MODELLEME ÇALIŞMALARI

Tugba ERTAN-BOLELLİ, Kayhan BOLELLİ

ORIGANUM MINUTIFLORUM'UN NB2A NÖROBLASTOMA HÜCRELERİNE APOPTOTİK VE SİTOTOKSİK ETKİSİ

İsmail SARİ, Gonca DÖNMEZ ARAT, Oktay ÖZKAN, İşil AYDEMİR, Caner ÖZBEY, Mehmet İbrahim TUĞLU

RASYONEL İLAÇ TASARIMINDA MOLEKÜLER MEKANİK VE MOLEKÜLER DİNAMİK YÖNTEMLERİN KULLANILMA AMACI

Dilara EREN, İsmail YALÇIN

PROLİPOZOM TEKNOLOJİSİNDEKİ GÜNCEL GELİŞMELER VE UYGULAMALAR

Zerrin SEZGİN BAYINDIR, Nadir DERELİ

İSTANBUL AKTARLARINDA SATILAN HYPERICUM PERFORATUM ÖRNEKLERİNİN FARMAKOGNOZİK AÇIDAN İNCELENMESİ

Ömerül Faruk TAVLI, Ömer HAZMAN, Ahmet BÜYÜKBEN, Fatıma Nur YILMAZ, Berna ÖZBEK ÇELİK, Esra EROĞLU ÖZKAN

COUSINIA CASS. CİNSİNİN GELENEKSEL KULLANIMI, FİTOKİMYASAL İÇERİĞİ VE BİYOLOJİK ETKİLERİ

Leyla PAŞAYEVA, Ayşe Cemre KARARENK, Müberra KOŞAR